MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation celebrates the opening of a new facility for its China operations. The new site for Shanghai Promega Biological Products, Ltd. both replaces an existing molecular biology reagent production site and it provides additional research, development and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market. Since its purchase in June of this year, the building has been equipped for the manufacture of molecular biology and molecular diagnostic reagents. Under the leadership of General Manager Tom Duan, a team of 40 scientists, technicians and administrators will begin operations in the new facility in the next few weeks.
